000			03828nam a22005897a 4500
008			190521s20192019 xxu||||| |||| 00| 0 eng d
022			_a1932-7501
024			_a01273116-201905000-00014 [pii]
024			_a10.1097/HCR.0000000000000433 [doi]
040			_aOvid MEDLINE(R)
099			_a31022006
245			_aReferral to Cardiac Rehabilitation and Outcomes for Patients With Takotsubo Cardiomyopathy.
251			_aJournal of Cardiopulmonary Rehabilitation & Prevention. 39(3):E8-E11, 2019 05.
252			_aJ Mol Signal. 39(3):E8-E11, 2019 05.
252			_zJ Mol Signal. 39(3):E8-E11, 2019 May.
253			_aJournal of cardiopulmonary rehabilitation and prevention
260			_c2019
260			_fFY2019
265			_sppublish
266			_d2019-05-21
268			_aJournal of Cardiopulmonary Rehabilitation & Prevention. 39(3):E8-E11, 2019 May.
501			_aAvailable online through MWHC library: 2007 - present
520			_aCONCLUSIONS: Referral for the TC population was low; however, enrollment and completion rates were adequate, with percutaneous coronary intervention in nonculprit vessel as the only predictor of CR referral. Limited data showed CR may help with weight reduction and improve exercise duration.
520			_aMETHODS: Patients at 2 academic medical centers with a discharge diagnosis of TC from January 2008 to March 2015 were retrospectively identified. Patients meeting the Mayo Clinic criteria for TC were cross-matched to the CR center affiliated with the hospitals to determine the referral rate and outcomes after completion of the program.
520			_aPURPOSE: The aim of this study was to determine participation rates and outcomes for patients with Takotsubo cardiomyopathy (TC) in a cardiac rehabilitation (CR) program.
520			_aRESULTS: In total, 380 unique patients were identified who survived the index hospitalization. Eighteen patients (5%) were referred to CR, 15 enrolled, and of those enrolled, 10 patients (67%) completed the program. Patients undergoing percutaneous coronary intervention of a nonculprit vessel at the time of diagnosis was the only predictor for referral to CR (11% vs 1%, P = .01). The 10 patients who completed CR attended 33 +/- 6 (range, 20-36) sessions. Weight and body mass index reduction were 2.8 +/- 3.5 lb and 0.6 +/- 0.7 kg/m (P = .04, both), respectively. Post-CR exercise duration was 37 +/- 4 min/session, which improved by 13 +/- 6 min/session from baseline (P < .01). Two patients entered the phase III maintenance program. One-year cardiac readmission rates were comparable among patients who completed CR and those who were referred but did not attend or complete CR (0% vs 13%, P = .47).
546			_aEnglish
650			_a*Cardiac Rehabilitation/mt [Methods]
650			_a*Exercise Therapy/mt [Methods]
650			_a*Exercise Tolerance/ph [Physiology]
650			_a*Referral and Consultation/sn [Statistics & Numerical Data]
650			_a*Rehabilitation Centers/sn [Statistics & Numerical Data]
650			_a*Takotsubo Cardiomyopathy/rh [Rehabilitation]
650			_aAged
650			_aCoronary Angiography
650			_aElectrocardiography
650			_aFemale
650			_aFollow-Up Studies
650			_aHospitalization/td [Trends]
650			_aHumans
650			_aMale
650			_aPrognosis
650			_aRetrospective Studies
650			_aTakotsubo Cardiomyopathy/di [Diagnosis]
650			_aTakotsubo Cardiomyopathy/pp [Physiopathology]
651			_aMedStar Heart & Vascular Institute
657			_aJournal Article
700			_aWu, Carolyn M
790			_aAbbott JD, Jiang L, McKeon J, Wu CM, Wu WC
856			_uhttps://dx.doi.org/10.1097/HCR.0000000000000433 _zhttps://dx.doi.org/10.1097/HCR.0000000000000433
942			_cART _dArticle
999			_c4271 _d4271